Aytu BioPharma News

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Yahoo Finance04:15

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Yahoo FinanceApr 3 19:00

Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceFeb 16 18:33

Earnings Call: Aytu BioPharma Achieves First Positive Operating Income

InvestingFeb 16 04:36

Q2 2024 Aytu Biopharma Inc Earnings Call

Yahoo FinanceFeb 15 18:49

Earnings Call Summary | Aytu BioPharma(AYTU.US) Q2 2024 Earnings Conference

The following is a summary of the Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript:Financial Performance:Aytu BioPharma achieved $5.1 million in adjusted EBITDA, up from the previous year'

Futu NewsFeb 15 12:32 · Conference Call

Aytu BioScience GAAP EPS of -$0.04 Beats by $0.21, Revenue of $22.93M Beats by $1.18M

Seeking AlphaFeb 15 05:20

Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, Vs. Street Est of $21.75M

04:07 PM EST, 02/14/2024 (MT Newswires) -- Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M

MT NewswiresFeb 15 05:07

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted E

AccesswireFeb 15 05:05

Earnings Scheduled For February 14, 2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. • CAE (NYSE:CAE) is estimated to report quarterl

BenzingaFeb 14 17:48

Earnings Preview: Aytu BioPharma

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here's what investors need to know before the announcement.Analysts estimate that Aytu BioPha

BenzingaFeb 14 03:02

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. , a pharmaceutical company focused on commercializing novel therapeutics, will report its

AccesswireFeb 8 05:15

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

AccesswireJan 23 22:02

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Yahoo FinanceJan 16 19:59

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Webcasted presentation to take place at 1:10pm ETDENVER, CO / ACCESSWIRE / November 30, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercia

AccesswireNov 30, 2023 21:00

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersTelesis Bio (NASDAQ:TBIO) shares increased by 32.5% to $0.53 during Wednesday's after-market session. The company's market cap stands at $15.8 million. Femasys (NASDAQ:FEMY) shares rose 19.28%

BenzingaNov 23, 2023 05:31

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersHeron Therapeutics (NASDAQ:HRTX) stock moved upwards by 63.0% to $0.88 during Wednesday's regular session. As of 12:31 EST, Heron Therapeutics's stock is trading at a volume of 15.8 million, wh

BenzingaNov 16, 2023 01:31

Top 10 Stocks Under $10, as Ranked by SA's Quant Ratings

Seeking AlphaNov 16, 2023 00:44

Aytu BioScience GAAP EPS of -$1.48 Misses by $1.44, Revenue of $22.1M Misses by $5.63M

Seeking AlphaNov 15, 2023 05:28